The Patent Finder

Eagle Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Eagle Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 37 patents it holds.

Back to Eagle Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,803,762Ready-To-Use Bivalirudin Compositions
now held by Sandoz Inc.
In force
 · Medium confidence
In forceMedium confidence
US 7,713,928Ready-To-Use Bivalirudin Compositions
now held by Sandoz Inc.
In force
 · Medium confidence
In forceMedium confidence
US 12,582,633Methods of Treating Severe Acute Respiratory Syndrome
In force
 · High confidence
In forceHigh confidence
US 12,605,364Methods of Treating SARS-COV-2 Infections
In force
 · High confidence
In forceHigh confidence
US 8,815,833Stable amifostine liquid concentrate
now held by Scidose, LLC
Lapsed on the fee record
Ended Aug 26, 2018 · High confidence
Lapsed on the fee recordEnded Aug 26, 2018High confidence
12/394,431Topotecan Ready to Use Solutions
Abandoned
Abandoned Dec 12, 2014
AbandonedAbandoned Dec 12, 2014
12/856,088Ready-To-Use Bivalirudin Compositions
Abandoned
Abandoned Jan 7, 2013
AbandonedAbandoned Jan 7, 2013
12/885,009Formulations of Daptomycin
now held by Scidose, LLC
Abandoned
Abandoned Apr 20, 2016
AbandonedAbandoned Apr 20, 2016
13/767,672Formulations of Bendamustine
Abandoned
Abandoned Mar 6, 2017
AbandonedAbandoned Mar 6, 2017
14/097,904Formulations of Bendamustine
Abandoned
Abandoned Jul 26, 2016
AbandonedAbandoned Jul 26, 2016
10 of 54 records shown.
Pro members see all 54.
Pro members: see all 54 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited